Nuveen, LLC Altimmune, Inc. Transaction History

Nuveen, LLC

  • $315 Billion
  • Q1 2025

A detailed history of Nuveen, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 263,898 shares of ALT stock, worth $952,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares
263,898
Holding current value
$952,671
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$5.0 - $7.45 $1.32 Million - $1.97 Million
263,898 New
263,898 $1.32 Million

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $177M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email